At the time of writing, Milestone Pharmaceuticals Inc [MIST] stock is trading at $1.54, up 3.36%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MIST shares have gain 5.48% over the last week, with a monthly amount drifted -29.03%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Rodman & Renshaw started tracking the stock with Buy rating on August 22, 2024, and set its price target to $9. On June 20, 2023, downgrade downgraded it’s rating to Hold and revised its price target to $4 on the stock. Piper Sandler upgraded its rating to a Overweight and increased its price target to $10 on April 22, 2022. H.C. Wainwright initiated its recommendation with a Buy and recommended $20 as its price target on March 05, 2021. Oppenheimer upgraded its rating to Outperform for this stock on July 29, 2020, but kept the price target unchanged to $18. In a note dated July 24, 2020, Jefferies upgraded an Buy rating on this stock.
For the past year, the stock price of Milestone Pharmaceuticals Inc fluctuated between $0.63 and $2.75. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Milestone Pharmaceuticals Inc [NASDAQ: MIST] shares were valued at $1.54 at the most recent close of the market. An investor can expect a potential return of 549.35% based on the average MIST price forecast.
Analyzing the MIST fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -1.98 and Total Capital is -1.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -9.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Milestone Pharmaceuticals Inc [NASDAQ:MIST] has a current ratio of 4.67. In addition, the Quick Ratio stands at 4.67 and the Cash Ratio stands at 3.48.
